News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Deuruxolitinib helps restore crowning glory in alopecia areata
25 Mar 2024
byAudrey Abella
Pooled analyses of the phase III THRIVEAA1 and THRIVE-AA2 trials underpin the potential of the selective oral JAK* 1/2 inhibitor deuruxolitinib to effectively and safely reverse hair loss in adults with moderate-to-severe alopecia areata (AA).
25 Mar 2024







